Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Anthrax 2018 NIAID 5R01AI033537-23 Virulence gene expression by Bacillus anthracis KOEHLER, THERESA UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $346,500
Anthrax 2018 NIGMS 5R01GM062357-16 Riboswitch mechanism unraveled at the single molecule level WALTER, NILS UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $377,877
Anthrax 2018 NIAID 5R01AI073843-10 Pathobiology of heme inducible transporters in Gram positive pathogens SKAAR, ERIC VANDERBILT UNIVERSITY MEDICAL CENTER TN $394,304
Anthrax 2018 NIAID 5R21AI125778-02 The Importance and Function of Heme Degrading Enzymes during Anthrax Disease MARESSO, ANTHONY BAYLOR COLLEGE OF MEDICINE TX $198,125
Anthrax 2018 NIAID 5R01AI110713-05 Analyzing a novel mechanism of action of bacterial cAMP producing toxins BIER, ETHAN UNIVERSITY OF CALIFORNIA, SAN DIEGO CA $537,892
Anthrax 2018 NIAID 5R41AI122666-02 Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis ADHIKARI, RAJAN INTEGRATED BIOTHERAPEUTICS, INC. MD $299,999
Anthrax 2018 NIAID 5R01AI111538-05 Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart RAO, VENIGALLA CATHOLIC UNIVERSITY OF AMERICA DC $776,353
Anthrax 2018 OD 5R01AI111538-05 Single Dose, Multivalent, Anthrax Plague Vaccines using Bacteriophage T4 Nanopart RAO, VENIGALLA CATHOLIC UNIVERSITY OF AMERICA DC $160,988
Anthrax 2018 NIAID 1R21AI131037-01A1 Development of a Multivalent Biodefense Vaccine KLOSE, KARL UNIVERSITY OF TEXAS SAN ANTONIO TX $198,250
Anthrax 2018 NIAID 5U19AI117892-04 8838 B Cell Population Dynamics in Affinity Maturation KELSOE, GARNETT DUKE UNIVERSITY NC $551,189
Anthrax 2018 NIAID 5U19AI117892-04 8839 Structures and Interactions of Antibodies Produced by Affinity Maturation HARRISON, STEPHEN BOSTON CHILDREN'S HOSPITAL MA $293,510
Anthrax 2018 NIAID 5U19AI109713-05 8682 Broad spectrum Tricyclics GyrB, ParE inhibitors for antibacterial applications BARTIZAL, KENNETH TRIUS THERAPEUTICS, INC. CA $533,298
Anthrax 2018 NIAID 2R01AI097167-05A1 Nutrient Uptake during Anthrax Disease MARESSO, ANTHONY BAYLOR COLLEGE OF MEDICINE TX $356,625
Anthrax 2018 NIAID 5F30AI110036-05 Assembly of the envelope of Bacillus anthracis vegetative forms LUNDERBERG, JUSTIN UNIVERSITY OF CHICAGO IL $27,574
Anthrax 2018 NIAID 5R37AI069227-12 Surface Proteins of Bacillus anthracis SCHNEEWIND, OLAF UNIVERSITY OF CHICAGO IL $405,000
Anthrax 2018 NIAID 5R01AI111495-05 Surface-enhanced Raman Spectroscopy Immunoassay for Detection of Category A Patho PORTER, MARC UNIVERSITY OF UTAH UT $610,286
Anthrax 2018 NIAID 5R21AI133001-02 Next-stage Development of Heme Transporters as a Vaccine for Anthrax MARESSO, ANTHONY BAYLOR COLLEGE OF MEDICINE TX $237,750
Anthrax 2018 NIGMS 5R01GM117617-04 Spatio-temporally explicit estimation of R0 for pathogens with environmentally-mediated transmission BLACKBURN, JASON UNIVERSITY OF FLORIDA FL $367,879
Anthrax 2018 NIAID 5R21AI125804-02 Mass Spectrometry Analysis of Lipid-Protein Interactions and Structural Heterogeneity in the Anthrax Toxin Pore PRELL, JAMES UNIVERSITY OF OREGON OR $218,430
Anthrax 2018 RMAP 5U01GM125289-02 Development of novel approaches for stereoselective construction of glycosidic linkages ZHANG, LIMING UNIVERSITY OF CALIFORNIA SANTA BARBARA CA $632,500
Anthrax 2018 NIAID 5U19AI062629-15 7600 Toxin-Mediated Suppression of Human PBMC Responses During Bacteremia BALLARD, JIMMY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $325,600
Anthrax 2018 NIAID 5U19AI062629-15 7601 Mechanisms by which B. anthracis Spores Escape the Lung METCALF, JORDAN UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $309,839
Anthrax 2018 NIAID 5U19AI062629-15 7602 Anti-Peptidoglycan Antibodies and Complement in Anthrax Pathogenesis COGGESHALL, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $442,924
Anthrax 2018 NIAID 5U19AI062629-15 7603 Humoral Mechanisms of Protection from Bacillus anthracis Sepsis FARRIS, A OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $688,318
Anthrax 2018 NIAID 5U19AI062629-15 7604 Administrative Core COGGESHALL, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $148,941
Anthrax 2018 NIAID 5U19AI062629-15 7605 Pilot Project Program BALLARD, JIMMY UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR OK $161,400
Anthrax 2018 NIAID 5U19AI062629-15 7606 Animal Model Core LUPU, FLOREA OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $559,359
Anthrax 2018 NIAID 5U19AI062629-15 7607 Flow Cytometry Core THOMPSON, LINDA OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $87,400
Anthrax 2018 NIAID 5U19AI062629-15 7608 Human Antibody Core SMITH, KENNETH OKLAHOMA MEDICAL RESEARCH FOUNDATION OK $174,800
Anthrax 2018 NIAID 5R01AI127658-04 Novel vita-vaccine formula combines safety of dead and efficacy of live vaccines BLANDER, JULIE WEILL MEDICAL COLL OF CORNELL UNIV NY $419,267
Anthrax 2018 NIAID 2R44AI118000-03 Preclinical development of teixobactin, a new antibiotic HUGHES, DALLAS NOVOBIOTIC PHARMACEUTICALS, LLC MA $999,040
Anthrax 2018 NIEHS 5R35ES028303-02 Mechanism of Eukaryotic Environmental Mutagenesis WALKER, GRAHAM MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $544,720
Anthrax 2018 NIAID 272201500012C-4-0-1 Optimizing Lead Therapeutic Compounds Against Infectious Diseases THALE, JARVIS CRESTONE, INC. CO $2,575,997
Anthrax 2018 NIAID 272201000013I-5-27200004-1 Task C19: Efficacy of amoxicillin and amoxicillin/clavulanate in NHP model of anthrax CARROLL, MILES PUBLIC HEALTH ENGLAND UK $347
Anthrax 2018 NIAID 272201200034C-11-0-1 Technologies to Advance Next Generation Anthrax Vaccines YUSIBOV, VIDADI CENTER FOR EXPERMENTAL SOFTWARE ENGR MD MD $405,532
Anthrax 2018 NCI 261200800001E-132-0-3 DCTD Computer Support HEIMBROOK, DAVID LEIDOS BIOMEDICAL RESEARCH, INC. MD $3,533,659
Anthrax 2018 NIAID 272201400038C-10-0-1 DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N LEMIALE, LAURENCE EMERGENT PRODUCT DEVELOPMENT GAITHERSBUR MD $2,484,726
Anthrax 2018 NIAID 272201700060C-4-0-12 Structural Genomics Centers for Infectious Diseases SATCHELL, KARLA NORTHWESTERN UNIVERSITY AT CHICAGO IL $383,198
Anthrax 2018 NIAID 272201100006I-0-27200004-1 Task A34: In vitro screening for antibacterial activity against biodefense and emerging infectious disease pathogens NO PI IDENTIFIED COLORADO STATE UNIVERSITY CO $159,933
Anthrax 2018 NIAID 1R56AI137258-01 Development of Teixobactin Analogues NOWICK, JAMES UNIVERSITY OF CALIFORNIA-IRVINE CA $443,833
Anthrax 2018 NIDDK 1ZIADK059701-45 Reactions And Immunochemistry Of Carbohydrates KOVAC, PAVOL NIH $799,147
Anthrax 2018 NIDDK 1ZIADK075081-07 Understanding metabolism and stress conditions of recombinant microorganisms SHILOACH, JOSEPH NIH $337,976
Anthrax 2018 NIAID 272201700040I-0-27200008-1 Task A12: Testing teixobactin in rabbit model of inhalational anthrax NO PI IDENTIFIED UNIVERSITY OF TEXAS MED BR GALVESTON TX $450,081
Anthrax 2018 NIAID 1ZIAAI000984-12 Influenza and Emerging Infectious Diseases DAVEY, RICHARD NIH $2,632,754
Anthrax 2018 NIAID N01AI30061-42-0-2 Testing of Antibiotics Against Anthrax MOTT, JASON BATTELLE CENTERS/PUB HLTH RES & EVALUATN OH $512,126
Anthrax 2018 NIAID 1ZIAAI000936-15 Pathogenesis, Treatment and Prevention of Emerging Infectious Diseases LANE, H. CLIFFORD NIH $226,923
Anthrax 2018 NIAID 272201700012I-0-27200005-1 Task A19: Determination of the Extent of Bacillus anthracis Spore Persistence in New Zealand White Rabbits after Prophylactic Treatment NO PI IDENTIFIED BATTELLE CENTERS/PUB HLTH RES & EVALUATN OH $712,518
Anthrax 2018 NIAID 1ZIAAI000929-16 Vaccines and Therapeutics for Anthrax LEPPLA, STEPHEN NIH $678,466
Anthrax 2018 NIAID 1ZIAAI001030-11 Molecular Genetics and Pathogenesis of Anthrax LEPPLA, STEPHEN NIH $387,695
Anthrax 2018 NIAID 1ZIAAI001031-11 Structure and Function of Virulence Factors of Bacillus anthracis LEPPLA, STEPHEN NIH $484,619
Anthrax 2018 NIAID 1ZIAAI001032-11 Pathophysiological Actions of Anthrax Virulence Determinants LEPPLA, STEPHEN NIH $387,695
Anthrax 2018 NIAID 272201600045C-4-0-1 VACCINE TECHNOLOGIES TO ADVANCE NEXT GENERATION ANTHRAX VACCINES TRANTER, HOWARD NIH $768,782
Anthrax 2018 NIAID 272201800023C-0-0-1 Development of a Therapeutic to Treat Anthrax in Humans NO PI IDENTIFIED HAWAII BIOTECH, INC. HI $12,124,546


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer